Cognitive Processing of Natural Sequences in Humans and Artificial Intelligence (AI) (SEQUOIA)
SEQUOIA : Cognitive Processing of Natural Sequences in Humans and Artificial Intelligence (AI)
The goal of this study is to identify electrical patterns in the cortex that enable the generation of predictions in natural auditory sequences such as speech and music.
Between 500 and 700 participants in total (250 to 350 normally hearing participants (including 60 to 120 participants from West Africa and 60 to 120 participants from Western Europe) and 250 to 350 participants with hearing loss (no restrictions on origin)).
Participants will listen to naturally recorded music and speech via headphones. They will be asked to rate these stimuli on a scale from 0 to 10 in terms of pleasure and comprehension, using a keyboard and mouse or voice input. Additionally, they will be required to sing or produce novel/improvised vocal responses using high-fidelity microphones. This entire procedure will be conducted under electroencephalography (EEG) to record neuronal responses throughout the process.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Estimé)
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
Hearing participants will be recruited from the general population in the Paris region.
We will also recruit participants with hearing impairment through ENT clinics, in hearing aid dispensing centers.
Finally, we will specifically recruit participants residing in Paris and of West African origin to examine differences related to cultural experience.
La description
Inclusion Criteria:
For hearing participants:
- Average pure-tone thresholds ≤ 20 dB HL
For participants with hearing loss:
- Average pure-tone thresholds > 20 dB HL
For participants of West African origin:
- Average pure-tone thresholds ≤ 20 dB HL
- Declare that both parents are of West African origin, either by their own birth or by the birth of both of their parents.
Exclusion Criteria:
- No known neurological or audiological disorders
- Participants under legal guardianship (tutelle, curatelle)
- Participants deprived of legal liberty by judicial or administrative decision
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Normal hearing participants from West Africa
|
|
Normal hearing participants from Western Europe
|
|
Participants with hearing loss
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Correlation between neural recordings and IA models
Délai: Day 1
|
To identify electrical patterns in cortex which generates predictions in natural auditory sequences (such as speak and music).
|
Day 1
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Compare predictions generated across different cultural contexts
Délai: Day 1
|
specifically, comparing West African and Western European communities in Paris
|
Day 1
|
|
Compare predictions for identical stimuli across repeated sessions to establish a link between processing and successful memorization/retention.
Délai: From enrollement to visit 2 (10 days)
|
From enrollement to visit 2 (10 days)
|
|
|
Compare predictions generated between hearing individuals and those with hearing impairments.
Délai: Day 2
|
Day 2
|
|
|
Correlate predictive measures with responses to autism symptom questionnaires across the various experiments.
Délai: Day 1
|
Day 1
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2024-102 SEQUOIA
- 2025-A00021-48 (Autre identifiant: ID-RCB)
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .